{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "marketState": "CLOSED", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 201.0, "exchange": "JPX", "shortName": "D.WESTERN THERAPEUTICS INST INC", "longName": "D. Western Therapeutics Institute, Inc.", "messageBoardId": "finmb_52322388", "exchangeTimezoneName": "Asia/Tokyo", "market": "jp_market", "regularMarketTime": 1683872101, "regularMarketDayHigh": 203.0, "regularMarketDayRange": "198.0 - 203.0", "regularMarketDayLow": 198.0, "regularMarketVolume": 92600, "regularMarketPreviousClose": 201.0, "bid": 199.0, "ask": 201.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 203.0, "averageDailyVolume3Month": 216065, "averageDailyVolume10Day": 96900, "fiftyTwoWeekLowChange": 3.0, "fiftyTwoWeekLowChangePercent": 0.015151516, "fiftyTwoWeekRange": "198.0 - 357.0", "fiftyTwoWeekHighChange": -156.0, "fiftyTwoWeekHighChangePercent": -0.4369748, "fiftyTwoWeekLow": 198.0, "fiftyTwoWeekHigh": 357.0, "earningsTimestamp": 1683873000, "earningsTimestampStart": 1691389800, "earningsTimestampEnd": 1691994600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -9.39, "sharesOutstanding": 31323200, "bookValue": 60.121, "fiftyDayAverage": 215.22, "fiftyDayAverageChange": -14.220001, "fiftyDayAverageChangePercent": -0.066071935, "twoHundredDayAverage": 248.54, "twoHundredDayAverageChange": -47.539993, "twoHundredDayAverageChangePercent": -0.19127704, "marketCap": 6295963136, "priceToBook": 3.343258, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1256256000000, "priceHint": 2, "regularMarketChange": 0.0, "symbol": "4576.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "CK21 Hirokoujifushimi Building", "address2": "7th Floor 1-18-11, Nishiki Naka-ku", "city": "Nagoya", "zip": "460-0003", "country": "Japan", "phone": "81 5 2218 8785", "fax": "81 5 2202 1866", "website": "https://www.dwti.co.jp", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on developing drugs to serve patients worldwide. The company offers GLANATEC, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM staining and peeling. It is also developing H-1337, a multikinase inhibitor that has completed Phase I/IIa clinical trials for the treatment of glaucoma/ocular hypertension; K-134, an antiplatelet agent, which has completed Phase IIb trials to treat arteriosclerosis obliterans; DW-1001, an ophthalmic treatment agent in nonclinical studies; and DW-5LBT, a lidocaine patch for neuropathic pain after shingles. The company was founded in 1999 and is headquartered in Nagoya, Japan.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Mr. Yuichi  Hidaka", "age": 49, "title": "Pres, CEO & Representative Director", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tetsuya  Kawakami", "age": 57, "title": "GM of Admin. Division & Director", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}